GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bukwang Pharmaceutical Co Ltd (XKRX:003000) » Definitions » EV-to-EBITDA

Bukwang Pharmaceutical Co (XKRX:003000) EV-to-EBITDA : -11.53 (As of May. 05, 2024)


View and export this data going back to 1988. Start your Free Trial

What is Bukwang Pharmaceutical Co EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Bukwang Pharmaceutical Co's enterprise value is ₩362,847 Mil. Bukwang Pharmaceutical Co's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was ₩-31,469 Mil. Therefore, Bukwang Pharmaceutical Co's EV-to-EBITDA for today is -11.53.

The historical rank and industry rank for Bukwang Pharmaceutical Co's EV-to-EBITDA or its related term are showing as below:

XKRX:003000' s EV-to-EBITDA Range Over the Past 10 Years
Min: -2926.37   Med: 38.43   Max: 3083.5
Current: -11.53

During the past 13 years, the highest EV-to-EBITDA of Bukwang Pharmaceutical Co was 3083.50. The lowest was -2926.37. And the median was 38.43.

XKRX:003000's EV-to-EBITDA is ranked worse than
100% of 705 companies
in the Drug Manufacturers industry
Industry Median: 14.53 vs XKRX:003000: -11.53

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-05), Bukwang Pharmaceutical Co's stock price is ₩6350.00. Bukwang Pharmaceutical Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was ₩-469.000. Therefore, Bukwang Pharmaceutical Co's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Bukwang Pharmaceutical Co EV-to-EBITDA Historical Data

The historical data trend for Bukwang Pharmaceutical Co's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bukwang Pharmaceutical Co EV-to-EBITDA Chart

Bukwang Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 183.73 -2,700.82 80.77 89.50 -11.24

Bukwang Pharmaceutical Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 89.50 157.49 157.98 -30.70 -11.24

Competitive Comparison of Bukwang Pharmaceutical Co's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Bukwang Pharmaceutical Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bukwang Pharmaceutical Co's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bukwang Pharmaceutical Co's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Bukwang Pharmaceutical Co's EV-to-EBITDA falls into.



Bukwang Pharmaceutical Co EV-to-EBITDA Calculation

Bukwang Pharmaceutical Co's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=362846.887/-31469.375
=-11.53

Bukwang Pharmaceutical Co's current Enterprise Value is ₩362,847 Mil.
Bukwang Pharmaceutical Co's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-31,469 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bukwang Pharmaceutical Co  (XKRX:003000) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Bukwang Pharmaceutical Co's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=6350.00/-469.000
=At Loss

Bukwang Pharmaceutical Co's share price for today is ₩6350.00.
Bukwang Pharmaceutical Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-469.000.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Bukwang Pharmaceutical Co EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Bukwang Pharmaceutical Co's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Bukwang Pharmaceutical Co (XKRX:003000) Business Description

Traded in Other Exchanges
N/A
Address
398-1 Daebang-Dong, Dongjak-Gu, Seoul, KOR
Bukwang Pharmaceutical Co Ltd manufactures and markets medicines for diabetes, hepatitis B, anticancer and psychiatry. The Company's OTC products focus on dental treatment. The company also engages in venture business and bio engineering.

Bukwang Pharmaceutical Co (XKRX:003000) Headlines

No Headlines